BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li X, Fan Z. The epidermal growth factor receptor antibody cetuximab induces autophagy in cancer cells by downregulating HIF-1alpha and Bcl-2 and activating the beclin 1/hVps34 complex. Cancer Res 2010;70:5942-52. [PMID: 20634405 DOI: 10.1158/0008-5472.CAN-10-0157] [Cited by in Crossref: 136] [Cited by in F6Publishing: 78] [Article Influence: 12.4] [Reference Citation Analysis]
Number Citing Articles
1 Rontogianni S, Iskit S, van Doorn S, Peeper DS, Altelaar M. Combined EGFR and ROCK Inhibition in Triple-negative Breast Cancer Leads to Cell Death Via Impaired Autophagic Flux. Mol Cell Proteomics 2020;19:261-77. [PMID: 31772060 DOI: 10.1074/mcp.RA119.001800] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Boeckx C, Van den Bossche J, De Pauw I, Peeters M, Lardon F, Baay M, Wouters A. The hypoxic tumor microenvironment and drug resistance against EGFR inhibitors: preclinical study in cetuximab-sensitive head and neck squamous cell carcinoma cell lines. BMC Res Notes 2015;8:203. [PMID: 26032726 DOI: 10.1186/s13104-015-1197-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
3 Wise R, Zolkiewska A. Metalloprotease-dependent activation of EGFR modulates CD44+/CD24- populations in triple negative breast cancer cells through the MEK/ERK pathway. Breast Cancer Res Treat 2017;166:421-33. [PMID: 28791489 DOI: 10.1007/s10549-017-4440-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
4 Tan X, Thapa N, Sun Y, Anderson RA. A kinase-independent role for EGF receptor in autophagy initiation. Cell 2015;160:145-60. [PMID: 25594178 DOI: 10.1016/j.cell.2014.12.006] [Cited by in Crossref: 129] [Cited by in F6Publishing: 134] [Article Influence: 21.5] [Reference Citation Analysis]
5 Zhang Z, Lian X, Xie W, Quan J, Liao M, Wu Y, Yang ZZ, Wang G. Role of PARP1-mediated autophagy in EGFR-TKI resistance in non-small cell lung cancer. Sci Rep 2020;10:20924. [PMID: 33262410 DOI: 10.1038/s41598-020-77908-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 De Pauw I, Lardon F, Van den Bossche J, Baysal H, Fransen E, Deschoolmeester V, Pauwels P, Peeters M, Vermorken JB, Wouters A. Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines. Mol Oncol 2018;12:830-54. [PMID: 29603584 DOI: 10.1002/1878-0261.12197] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
7 Law BY, Mok SW, Wu AG, Lam CW, Yu MX, Wong VK. New Potential Pharmacological Functions of Chinese Herbal Medicines via Regulation of Autophagy. Molecules. 2016;21:359. [PMID: 26999089 DOI: 10.3390/molecules21030359] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
8 Heaster TM, Landman BA, Skala MC. Quantitative Spatial Analysis of Metabolic Heterogeneity Across in vivo and in vitro Tumor Models. Front Oncol 2019;9:1144. [PMID: 31737571 DOI: 10.3389/fonc.2019.01144] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
9 Rubinsztein DC, Codogno P, Levine B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov. 2012;11:709-730. [PMID: 22935804 DOI: 10.1038/nrd3802] [Cited by in Crossref: 985] [Cited by in F6Publishing: 950] [Article Influence: 109.4] [Reference Citation Analysis]
10 Chern YJ, Tai IT. Adaptive response of resistant cancer cells to chemotherapy. Cancer Biol Med. 2020;17:842-863. [PMID: 33299639 DOI: 10.20892/j.issn.2095-3941.2020.0005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Ray P, Tan YS, Somnay V, Mehta R, Sitto M, Ahsan A, Nyati S, Naughton JP, Bridges A, Zhao L, Rehemtulla A, Lawrence TS, Ray D, Nyati MK. Differential protein stability of EGFR mutants determines responsiveness to tyrosine kinase inhibitors. Oncotarget 2016;7:68597-613. [PMID: 27612423 DOI: 10.18632/oncotarget.11860] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
12 Shen J, Zheng H, Ruan J, Fang W, Li A, Tian G, Niu X, Luo S, Zhao P. Autophagy inhibition induces enhanced proapoptotic effects of ZD6474 in glioblastoma. Br J Cancer 2013;109:164-71. [PMID: 23799852 DOI: 10.1038/bjc.2013.306] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 6.9] [Reference Citation Analysis]
13 Fung C, Chen X, Grandis JR, Duvvuri U. EGFR tyrosine kinase inhibition induces autophagy in cancer cells. Cancer Biol Ther 2012;13:1417-24. [PMID: 22954701 DOI: 10.4161/cbt.22002] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 7.6] [Reference Citation Analysis]
14 Teng K, Zhang Y, Hu X, Ding Y, Gong R, Liu L. Nimotuzumab enhances radiation sensitivity of NSCLC H292 cells in vitro by blocking epidermal growth factor receptor nuclear translocation and inhibiting radiation-induced DNA damage repair. Onco Targets Ther 2015;8:809-18. [PMID: 25926742 DOI: 10.2147/OTT.S77283] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
15 Tanei T, Choi DS, Rodriguez AA, Liang DH, Dobrolecki L, Ghosh M, Landis MD, Chang JC. Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells. Breast Cancer Res. 2016;18:6. [PMID: 26757880 DOI: 10.1186/s13058-015-0662-4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 6.4] [Reference Citation Analysis]
16 Han W, Pan H, Chen Y, Sun J, Wang Y, Li J, Ge W, Feng L, Lin X, Wang X, Wang X, Jin H. EGFR tyrosine kinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells. PLoS One 2011;6:e18691. [PMID: 21655094 DOI: 10.1371/journal.pone.0018691] [Cited by in Crossref: 160] [Cited by in F6Publishing: 154] [Article Influence: 16.0] [Reference Citation Analysis]
17 Yang ZJ, Chee CE, Huang S, Sinicrope FA. The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther. 2011;10:1533-1541. [PMID: 21878654 DOI: 10.1158/1535-7163.mct-11-0047] [Cited by in Crossref: 766] [Cited by in F6Publishing: 484] [Article Influence: 76.6] [Reference Citation Analysis]
18 Jutten B, Rouschop KM. EGFR signaling and autophagy dependence for growth, survival, and therapy resistance. Cell Cycle. 2014;13:42-51. [PMID: 24335351 DOI: 10.4161/cc.27518] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 8.3] [Reference Citation Analysis]
19 You L, Shou J, Deng D, Jiang L, Jing Z, Yao J, Li H, Xie J, Wang Z, Pan Q, Pan H, Huang W, Han W. Crizotinib induces autophagy through inhibition of the STAT3 pathway in multiple lung cancer cell lines. Oncotarget 2015;6:40268-82. [PMID: 26384345 DOI: 10.18632/oncotarget.5592] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 6.2] [Reference Citation Analysis]
20 Lu Y, Li X, Lu H, Fan Z. 1, 9-Pyrazoloanthrones downregulate HIF-1α and sensitize cancer cells to cetuximab-mediated anti-EGFR therapy. PLoS One 2010;5:e15823. [PMID: 21209911 DOI: 10.1371/journal.pone.0015823] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
21 Lima RT, Sousa D, Paiva AM, Palmeira A, Barbosa J, Pedro M, Pinto MM, Sousa E, Vasconcelos MH. Modulation of Autophagy by a Thioxanthone Decreases the Viability of Melanoma Cells. Molecules 2016;21:E1343. [PMID: 27735867 DOI: 10.3390/molecules21101343] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.6] [Reference Citation Analysis]
22 Becker MN, Wu KJ, Marlow LA, Kreinest PA, Vonroemeling CA, Copland JA, Williams CR. The combination of an mTORc1/TORc2 inhibitor with lapatinib is synergistic in bladder cancer in vitro. Urol Oncol 2014;32:317-26. [PMID: 24054871 DOI: 10.1016/j.urolonc.2013.06.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
23 Ho CJ, Gorski SM. Molecular Mechanisms Underlying Autophagy-Mediated Treatment Resistance in Cancer. Cancers (Basel) 2019;11:E1775. [PMID: 31717997 DOI: 10.3390/cancers11111775] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 15.5] [Reference Citation Analysis]
24 Fan J, Zeng X, Li Y, Wang S, Wang Z, Sun Y, Gao H, Zhang G, Feng M, Ju D. Autophagy plays a critical role in ChLym-1-induced cytotoxicity of non-hodgkin's lymphoma cells. PLoS One 2013;8:e72478. [PMID: 24015249 DOI: 10.1371/journal.pone.0072478] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
25 Guo GF, Jiang WQ, Zhang B, Cai YC, Xu RH, Chen XX, Wang F, Xia LP. Autophagy-related proteins Beclin-1 and LC3 predict cetuximab efficacy in advanced colorectal cancer. World J Gastroenterol 2011; 17(43): 4779-4786 [PMID: 22147978 DOI: 10.3748/wjg.v17.i43.4779] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 45] [Article Influence: 5.0] [Reference Citation Analysis]
26 Henson E, Chen Y, Gibson S. EGFR Family Members' Regulation of Autophagy Is at a Crossroads of Cell Survival and Death in Cancer. Cancers (Basel) 2017;9:E27. [PMID: 28338617 DOI: 10.3390/cancers9040027] [Cited by in Crossref: 42] [Cited by in F6Publishing: 50] [Article Influence: 10.5] [Reference Citation Analysis]
27 Cheng Y, Ren X, Hait WN, Yang JM. Therapeutic targeting of autophagy in disease: biology and pharmacology. Pharmacol Rev. 2013;65:1162-1197. [PMID: 23943849 DOI: 10.1124/pr.112.007120] [Cited by in Crossref: 152] [Cited by in F6Publishing: 146] [Article Influence: 19.0] [Reference Citation Analysis]
28 Yang ZJ, Chee CE, Huang S, Sinicrope F. Autophagy modulation for cancer therapy. Cancer Biol Ther 2011;11:169-76. [PMID: 21263212 DOI: 10.4161/cbt.11.2.14663] [Cited by in Crossref: 94] [Cited by in F6Publishing: 92] [Article Influence: 9.4] [Reference Citation Analysis]
29 Volz NB, Hanna DL, Stintzing S, Zhang W, Yang D, Cao S, Ning Y, Matsusaka S, Sunakawa Y, Berger MD, Cremolini C, Loupakis F, Falcone A, Lenz HJ. Polymorphisms within Immune Regulatory Pathways Predict Cetuximab Efficacy and Survival in Metastatic Colorectal Cancer Patients. Cancers (Basel) 2020;12:E2947. [PMID: 33065994 DOI: 10.3390/cancers12102947] [Reference Citation Analysis]
30 Rikiishi H. Autophagic action of new targeting agents in head and neck oncology. Cancer Biol Ther 2012;13:978-91. [PMID: 22825332 DOI: 10.4161/cbt.21079] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
31 Zeng X, Zhang H, Oh A, Zhang Y, Yee D. Enhancement of doxorubicin cytotoxicity of human cancer cells by tyrosine kinase inhibition of insulin receptor and type I IGF receptor. Breast Cancer Res Treat 2012;133:117-26. [PMID: 21850397 DOI: 10.1007/s10549-011-1713-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
32 Li X, Chu S, Liu Y, Chen N. Neuroprotective Effects of Anthraquinones from Rhubarb in Central Nervous System Diseases. Evid Based Complement Alternat Med 2019;2019:3790728. [PMID: 31223328 DOI: 10.1155/2019/3790728] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
33 Ojha R, Bhattacharyya S, Singh SK. Autophagy in Cancer Stem Cells: A Potential Link Between Chemoresistance, Recurrence, and Metastasis. Biores Open Access 2015;4:97-108. [PMID: 26309786 DOI: 10.1089/biores.2014.0035] [Cited by in Crossref: 80] [Cited by in F6Publishing: 75] [Article Influence: 13.3] [Reference Citation Analysis]
34 Li X, Lu Y, Pan T, Fan Z. Roles of autophagy in cetuximab-mediated cancer therapy against EGFR. Autophagy 2010;6:1066-77. [PMID: 20864811 DOI: 10.4161/auto.6.8.13366] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 6.6] [Reference Citation Analysis]
35 Bareford MD, Park MA, Yacoub A, Hamed HA, Tang Y, Cruickshanks N, Eulitt P, Hubbard N, Tye G, Burow ME, Fisher PB, Moran RG, Nephew KP, Grant S, Dent P. Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells. Cancer Res. 2011;71:4955-4967. [PMID: 21622715 DOI: 10.1158/0008-5472.can-11-0898] [Cited by in Crossref: 69] [Cited by in F6Publishing: 47] [Article Influence: 6.9] [Reference Citation Analysis]
36 Lei Y, Wang S, Ren B, Wang J, Chen J, Lu J, Zhan S, Fu Y, Huang L, Tan J. CHOP favors endoplasmic reticulum stress-induced apoptosis in hepatocellular carcinoma cells via inhibition of autophagy. PLoS One 2017;12:e0183680. [PMID: 28841673 DOI: 10.1371/journal.pone.0183680] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 11.8] [Reference Citation Analysis]
37 Tang Y, Hamed HA, Cruickshanks N, Fisher PB, Grant S, Dent P. Obatoclax and lapatinib interact to induce toxic autophagy through NOXA. Mol Pharmacol 2012;81:527-40. [PMID: 22219388 DOI: 10.1124/mol.111.076851] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
38 Han X, Wang Z, Hu B, Xu J. Autophagy inhibition contributes to Endostar sensitization in esophageal squamous cell carcinoma. Oncol Lett 2017;14:6604-10. [PMID: 29163691 DOI: 10.3892/ol.2017.7017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Fong W, To KKW. Drug repurposing to overcome resistance to various therapies for colorectal cancer. Cell Mol Life Sci 2019;76:3383-406. [PMID: 31087119 DOI: 10.1007/s00018-019-03134-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
40 Qi M, Tian Y, Li W, Li D, Zhao T, Yang Y, Li Q, Chen S, Yang Y, Zhang Z, Tang L, Liu Z, Su B, Li F, Feng Y, Fei K, Zhang P, Zhang F, Zhang L. ERK inhibition represses gefitinib resistance in non-small cell lung cancer cells. Oncotarget 2018;9:12020-34. [PMID: 29552290 DOI: 10.18632/oncotarget.24147] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
41 Zheng LQ, Li SY, Li CX. Expression profiling analysis of autophagy-related genes in perineural invasion of cutaneous squamous cell carcinoma. Oncol Lett 2018;15:4837-48. [PMID: 29552123 DOI: 10.3892/ol.2018.7971] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
42 Ngabire D, Kim GD. Autophagy and Inflammatory Response in the Tumor Microenvironment. Int J Mol Sci 2017;18:E2016. [PMID: 28930154 DOI: 10.3390/ijms18092016] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
43 Cui J, Hu YF, Feng XM, Tian T, Guo YH, Ma JW, Nan KJ, Zhang HY. EGFR inhibitors and autophagy in cancer treatment. Tumour Biol 2014;35:11701-9. [PMID: 25293518 DOI: 10.1007/s13277-014-2660-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
44 Li YY, Feun LG, Thongkum A, Tu CH, Chen SM, Wangpaichitr M, Wu C, Kuo MT, Savaraj N. Autophagic Mechanism in Anti-Cancer Immunity: Its Pros and Cons for Cancer Therapy. Int J Mol Sci 2017;18:E1297. [PMID: 28629173 DOI: 10.3390/ijms18061297] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
45 Rio-Vilariño A, Del Puerto-Nevado L, García-Foncillas J, Cebrián A. Ras Family of Small GTPases in CRC: New Perspectives for Overcoming Drug Resistance. Cancers (Basel) 2021;13:3757. [PMID: 34359657 DOI: 10.3390/cancers13153757] [Reference Citation Analysis]
46 Lu S, Ahmed T, Du P, Wang Y. Genomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment. Int J Mol Sci 2017;18:E1201. [PMID: 28587243 DOI: 10.3390/ijms18061201] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
47 Lampada A, O'Prey J, Szabadkai G, Ryan KM, Hochhauser D, Salomoni P. mTORC1-independent autophagy regulates receptor tyrosine kinase phosphorylation in colorectal cancer cells via an mTORC2-mediated mechanism. Cell Death Differ 2017;24:1045-62. [PMID: 28475179 DOI: 10.1038/cdd.2017.41] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
48 Pan H, Wang Z, Jiang L, Sui X, You L, Shou J, Jing Z, Xie J, Ge W, Cai X. Autophagy inhibition sensitizes hepatocellular carcinoma to the multikinase inhibitor linifanib. Sci Rep. 2014;4:6683. [PMID: 25327881 DOI: 10.1038/srep06683] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
49 Lei Y, Kansy BA, Li J, Cong L, Liu Y, Trivedi S, Wen H, Ting JP, Ouyang H, Ferris RL. EGFR-targeted mAb therapy modulates autophagy in head and neck squamous cell carcinoma through NLRX1-TUFM protein complex. Oncogene 2016;35:4698-707. [PMID: 26876213 DOI: 10.1038/onc.2016.11] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 6.4] [Reference Citation Analysis]
50 Cufí S, Vazquez-Martin A, Oliveras-Ferraros C, Corominas-Faja B, Urruticoechea A, Martin-Castillo B, Menendez JA. Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatment. Oncotarget 2012;3:1600-14. [PMID: 23307622 DOI: 10.18632/oncotarget.742] [Cited by in Crossref: 47] [Cited by in F6Publishing: 52] [Article Influence: 5.9] [Reference Citation Analysis]
51 Wang Z, Martin D, Molinolo AA, Patel V, Iglesias-Bartolome R, Degese MS, Vitale-Cross L, Chen Q, Gutkind JS. mTOR co-targeting in cetuximab resistance in head and neck cancers harboring PIK3CA and RAS mutations. J Natl Cancer Inst 2014;106:dju215. [PMID: 25099740 DOI: 10.1093/jnci/dju215] [Cited by in Crossref: 64] [Cited by in F6Publishing: 73] [Article Influence: 9.1] [Reference Citation Analysis]
52 Xu Y, Xia X, Pan H. Active autophagy in the tumor microenvironment: A novel mechanism for cancer metastasis. Oncol Lett 2013;5:411-6. [PMID: 23420500 DOI: 10.3892/ol.2012.1015] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
53 Tan X, Lambert PF, Rapraeger AC, Anderson RA. Stress-induced EGFR trafficking: mechanisms, functions, and therapeutic implications. Trends Cell Biol. 2016;26:352-366. [PMID: 26827089 DOI: 10.1016/j.tcb.2015.12.006] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 15.4] [Reference Citation Analysis]
54 Li X, Lu Y, Lu H, Luo J, Hong Y, Fan Z. AMPK-mediated energy homeostasis and associated metabolic effects on cancer cell response and resistance to cetuximab. Oncotarget 2015;6:11507-18. [PMID: 25871473 DOI: 10.18632/oncotarget.3432] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
55 Terzuoli E, Nannelli G, Frosini M, Giachetti A, Ziche M, Donnini S. Inhibition of cell cycle progression by the hydroxytyrosol-cetuximab combination yields enhanced chemotherapeutic efficacy in colon cancer cells. Oncotarget 2017;8:83207-24. [PMID: 29137335 DOI: 10.18632/oncotarget.20544] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
56 Zhavoronkov A, Smit-McBride Z, Guinan KJ, Litovchenko M, Moskalev A. Potential therapeutic approaches for modulating expression and accumulation of defective lamin A in laminopathies and age-related diseases. J Mol Med (Berl) 2012;90:1361-89. [PMID: 23090008 DOI: 10.1007/s00109-012-0962-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
57 Folkerts H, Hilgendorf S, Vellenga E, Bremer E, Wiersma VR. The multifaceted role of autophagy in cancer and the microenvironment. Med Res Rev 2019;39:517-60. [PMID: 30302772 DOI: 10.1002/med.21531] [Cited by in Crossref: 61] [Cited by in F6Publishing: 66] [Article Influence: 20.3] [Reference Citation Analysis]
58 Luo J, Hong Y, Lu Y, Qiu S, Chaganty BK, Zhang L, Wang X, Li Q, Fan Z. Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab. Cancer Lett 2017;384:39-49. [PMID: 27693630 DOI: 10.1016/j.canlet.2016.09.020] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 7.4] [Reference Citation Analysis]
59 Meng S, Wang G, Lu Y, Fan Z. Functional cooperation between HIF-1α and c-Jun in mediating primary and acquired resistance to gefitinib in NSCLC cells with activating mutation of EGFR. Lung Cancer 2018;121:82-90. [PMID: 29858032 DOI: 10.1016/j.lungcan.2018.04.024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
60 Carew JS, Kelly KR, Nawrocki ST. Autophagy as a target for cancer therapy: new developments. Cancer Manag Res. 2012;4:357-365. [PMID: 23091399 DOI: 10.2147/CMAR.S26133] [Cited by in Crossref: 16] [Cited by in F6Publishing: 62] [Article Influence: 1.8] [Reference Citation Analysis]
61 Patel U, Pandey M, Kannan S, Samant TA, Gera P, Mittal N, Rane S, Patil A, Noronha V, Joshi A, Patil VM, Prabhash K, Mahimkar MB. Prognostic and predictive significance of nuclear HIF1α expression in locally advanced HNSCC patients treated with chemoradiation with or without nimotuzumab. Br J Cancer 2020;123:1757-66. [PMID: 32939054 DOI: 10.1038/s41416-020-01064-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Liu J, Zhang Y, Qu J, Xu L, Hou K, Zhang J, Qu X, Liu Y. β-Elemene-induced autophagy protects human gastric cancer cells from undergoing apoptosis. BMC Cancer. 2011;11:183. [PMID: 21595977 DOI: 10.1186/1471-2407-11-183] [Cited by in Crossref: 94] [Cited by in F6Publishing: 88] [Article Influence: 9.4] [Reference Citation Analysis]
63 Guo GF, Wang YX, Zhang YJ, Chen XX, Lu JB, Wang HH, Jiang C, Qiu HQ, Xia LP. Predictive and prognostic implications of 4E-BP1, Beclin-1, and LC3 for cetuximab treatment combined with chemotherapy in advanced colorectal cancer with wild-type KRAS: Analysis from real-world data. World J Gastroenterol 2019; 25(15): 1840-1853 [PMID: 31057298 DOI: 10.3748/wjg.v25.i15.1840] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
64 Dong M, Wan XB, Yuan ZY, Wei L, Fan XJ, Wang TT, Lv YC, Li X, Chen ZH, Chen J, Lin Q, Wen JY, Ma XK, Liu Q, Wu XY. Low expression of Beclin 1 and elevated expression of HIF-1α refine distant metastasis risk and predict poor prognosis of ER-positive, HER2-negative breast cancer. Med Oncol 2013;30:355. [PMID: 23408367 DOI: 10.1007/s12032-012-0355-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
65 Yu C, Hong H, Lu J, Zhao X, Hu W, Zhang S, Zong Y, Mao Z, Li J, Wang M, Feng B, Sun J, Zheng M. Prediction of Target Genes and Pathways Associated With Cetuximab Insensitivity in Colorectal Cancer. Technol Cancer Res Treat. 2018;17:1533033818806905. [PMID: 30336768 DOI: 10.1177/1533033818806905] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
66 Lista P, Straface E, Brunelleschi S, Franconi F, Malorni W. On the role of autophagy in human diseases: a gender perspective. J Cell Mol Med 2011;15:1443-57. [PMID: 21362130 DOI: 10.1111/j.1582-4934.2011.01293.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 5.0] [Reference Citation Analysis]
67 Yu P, Zhang J, Yu S, Luo Z, Hua F, Yuan L, Zhou Z, Liu Q, Du X, Chen S, Zhang L, Xu G. Protective Effect of Sevoflurane Postconditioning against Cardiac Ischemia/Reperfusion Injury via Ameliorating Mitochondrial Impairment, Oxidative Stress and Rescuing Autophagic Clearance. PLoS One 2015;10:e0134666. [PMID: 26263161 DOI: 10.1371/journal.pone.0134666] [Cited by in Crossref: 42] [Cited by in F6Publishing: 50] [Article Influence: 7.0] [Reference Citation Analysis]
68 Tekedereli I, Alpay SN, Akar U, Yuca E, Ayugo-Rodriguez C, Han HD, Sood AK, Lopez-Berestein G, Ozpolat B. Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (-) and ER (+) Breast Cancer. Mol Ther Nucleic Acids. 2013;2:e121. [PMID: 24022053 DOI: 10.1038/mtna.2013.45] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 6.4] [Reference Citation Analysis]
69 Ge J, Chen Z, Huang J, Chen J, Yuan W, Deng Z, Chen Z. Upregulation of autophagy-related gene-5 (ATG-5) is associated with chemoresistance in human gastric cancer. PLoS One. 2014;9:e110293. [PMID: 25329677 DOI: 10.1371/journal.pone.0110293] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 8.1] [Reference Citation Analysis]
70 Shah AT, Heaster TM, Skala MC. Metabolic Imaging of Head and Neck Cancer Organoids. PLoS One 2017;12:e0170415. [PMID: 28099487 DOI: 10.1371/journal.pone.0170415] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 7.3] [Reference Citation Analysis]
71 Lee JG, Wu R. Combination erlotinib-cisplatin and Atg3-mediated autophagy in erlotinib resistant lung cancer. PLoS One 2012;7:e48532. [PMID: 23119048 DOI: 10.1371/journal.pone.0048532] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
72 Chang H, Zou Z. Targeting autophagy to overcome drug resistance: further developments. J Hematol Oncol 2020;13:159. [PMID: 33239065 DOI: 10.1186/s13045-020-01000-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
73 Yu P, Zhang Y, Li C, Li Y, Jiang S, Zhang X, Ding Z, Tu F, Wu J, Gao X, Li L. Class III PI3K-mediated prolonged activation of autophagy plays a critical role in the transition of cardiac hypertrophy to heart failure. J Cell Mol Med 2015;19:1710-9. [PMID: 25851780 DOI: 10.1111/jcmm.12547] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
74 Fraser J, Cabodevilla AG, Simpson J, Gammoh N. Interplay of autophagy, receptor tyrosine kinase signalling and endocytic trafficking. Essays Biochem 2017;61:597-607. [PMID: 29233871 DOI: 10.1042/EBC20170091] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
75 Shah AT, Diggins KE, Walsh AJ, Irish JM, Skala MC. In Vivo Autofluorescence Imaging of Tumor Heterogeneity in Response to Treatment. Neoplasia 2015;17:862-70. [PMID: 26696368 DOI: 10.1016/j.neo.2015.11.006] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 10.6] [Reference Citation Analysis]
76 Wang Z, Shi X, Li Y, Fan J, Zeng X, Xian Z, Wang Z, Sun Y, Wang S, Song P, Zhao S, Hu H, Ju D. Blocking autophagy enhanced cytotoxicity induced by recombinant human arginase in triple-negative breast cancer cells. Cell Death Dis 2014;5:e1563. [PMID: 25501824 DOI: 10.1038/cddis.2014.503] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
77 Yuan H, Li ZM, Shao J, Ji WX, Xia W, Lu S. FGF2/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells. J Exp Clin Cancer Res 2017;36:72. [PMID: 28558758 DOI: 10.1186/s13046-017-0534-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
78 Sui X, Kong N, Zhu M, Wang X, Lou F, Han W, Pan H. Cotargeting EGFR and autophagy signaling: A novel therapeutic strategy for non-small-cell lung cancer. Mol Clin Oncol 2014;2:8-12. [PMID: 24649300 DOI: 10.3892/mco.2013.187] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]